Surrozen, Inc.

US$31.00As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SRZNHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (24.75%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.56
PE TTM —
TSR TTM 121.43%
Mkt cap US$542.4M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$35
11.88%
(89.05%)
Hold 9|2|12|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.30
0.30
0.29
0.29
12.87%
5.70%
(2.07%)
1.52%
Revenue$M
29.15
29.16
30.67
30.76
2.34%
3.26%
8.83%
10.77%
Peers (US$542.4M)
Cap (US$)
PE
546.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.781
(0.037)
(0.040)
EBIT/Intx
1.595
1.336
0.973
Own earn%
(112.60)
(110.23)
(104.44)
Sh yield%
21.05
22.89
24.68
Owners
Insiders/Inst%
11.24
40.76
Short interest%
4.08
SBC / revenue%
1.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
13–19
$1 testx
0.1
Incr. ROIC%
11